Literature DB >> 1671797

Chronic alpha 1 blockade in a patient with Eisenmenger syndrome.

K Watanabe1, C Mori, N Haneda, M Inoue, K Kishida, Y Hayashi, H Ozasa.   

Abstract

In an 18-year-old male with Eisenmenger syndrome cyanosis and erythrocytosis were increasing. The erythrocytosis diminished following oral bunazosin and phlebotomy was not needed during the treatment. When bunazosin was stopped, the erythrocytosis increased, but when it was resumed, the erythrocytosis and general fatigue diminished.

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1671797     DOI： 10.1007/bf02238502

Source DB:  PubMed          Journal:  Pediatr Cardiol        ISSN： 0172-0643            Impact factor:   1.655


  8 in total

1.  Relationship between age, body size, gender, and blood pressure and Doppler flow measurements in the aorta and pulmonary artery.

Authors:  J M Gardin; D M Davidson; M K Rohan; S Butman; M Knoll; R Garcia; S Dubria; S K Gardin; W L Henry
Journal:  Am Heart J       Date:  1987-01       Impact factor: 4.749

2.  Inotropic, vascular and neuroendocrine effects of nifedipine in heart failure: comparison with nitroprusside.

Authors:  M A Fifer; W S Colucci; B H Lorell; B E Jaski; W H Barry
Journal:  J Am Coll Cardiol       Date:  1985-03       Impact factor: 24.094

3.  [Acute effect of a new alpha 1-receptor blocking drug, E-643, on severe congestive heart failure--pharmacokinetic and hemodynamic studies].

Authors:  K Itoh; T Kohya; H Nishijima; H Yasuda; S Minami; H Tsujinaga
Journal:  Kokyu To Junkan       Date:  1983-10

4.  Alpha blockade in pulmonary hypertension.

Authors:  A J Cottrell; D T Pearson; S Hunter
Journal:  Pediatr Cardiol       Date:  1982       Impact factor: 1.655

Review 5.  Vasodilator therapy for primary pulmonary hypertension. Limitations and hazards.

Authors:  M Packer
Journal:  Ann Intern Med       Date:  1985-08       Impact factor: 25.391

6.  Thromboxane synthetase inhibition in primary pulmonary hypertension.

Authors:  S Rich; K Hart; K Kieras; B H Brundage
Journal:  Chest       Date:  1987-03       Impact factor: 9.410

7.  Noninvasive evaluation of pulmonary hypertension by a pulsed Doppler technique.

Authors:  A Kitabatake; M Inoue; M Asao; T Masuyama; J Tanouchi; T Morita; M Mishima; M Uematsu; T Shimazu; M Hori; H Abe
Journal:  Circulation       Date:  1983-08       Impact factor: 29.690

8.  Clinical and echocardiographic evidence suggesting afterload reduction as a mechanism of action of tolazoline in neonatal hypoxemia.

Authors:  G G Sandor; A J Macnab; F A Akesode; V J Ebelt; M R Pendray; W Y Ling; M W Patterson; M A Tipple
Journal:  Pediatr Cardiol       Date:  1984 Apr-Jun       Impact factor: 1.655
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.